Distribution and drug resistance of pathogenic bacteria for infection after liver transplantation

Duo HAN; Hong HE; Hongwei WANG; Tingting TIAN; Jing LI

doi:10.3969/j.issn.1001-5256.2023.06.017

Volume 39 Issue 6

Jun. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(6): 1366-1373

PDF( 3720 KB)

Distribution and drug resistance of pathogenic bacteria for infection after liver transplantation

DOI: 10.3969/j.issn.1001-5256.2023.06.017

Duo HAN^{1, 2, 3},
Hong HE¹,
Hongwei WANG¹,
Tingting TIAN¹,
Jing LI^{1, 2
,
,
,}

1.
Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266061, China
2.
Department of Laboratory Medicine, Qingdao University School of Medicine, Qingdao, Shandong 266073, China
3.
Department of Clinical Laboratory, The People's Hospital of Zhoucun District, Zibo, Shandong 255300, China

Research funding:

Qingdao Medical and Health Excellent Young Medical Talents Project (2019YQ014);

Youth Research Fund of Affiliated Hospital of Qingdao University (QDFY2019022)

More Information

Corresponding author: LI Jing, qdjingl@163.com (ORCID: 0000-0001-7484-7720)
Received Date: 2022-10-25
Accepted Date: 2022-11-28
Published Date: 2023-06-20

Abstract

Abstract

Objective To investigate the distribution and drug resistance of pathogenic bacteria for infection after liver transplantation, and to provide a scientific basis for the rational clinical application of antibiotics. Methods The pathogenic bacteria isolated from the specimens of 904 patients with infection after liver transplantation in The Affiliated Hospital of Qingdao University from March 2014 to December 2021 were analyzed in terms of distribution and drug resistance. WHONET 5.6 software was used to perform a statistical analysis of strains and bacterial resistance rate, and Excel was used to analyze the sources of specimens, composition ratios, and distribution of pathogenic bacteria. Results A total of 2 208 non-repetitive pathogenic bacteria were isolated, mainly from the specimens of respiratory tract (31.25%), bile (22.28%), ascites (13.18%), blood (8.38%), and drainage fluid (4.62%). The top 10 pathogenic bacteria were Klebsiella pneumoniae subspecies (10.69%), Enterococcus faecium (10.42%), Escherichia coli (8.24%), Pseudomonas aeruginosa (8.24%), Staphylococcus epidermidis (8.06%), Acinetobacter baumannii (7.93%), Stenotrophomonas maltophilia (6.61%), Enterobacter cloacae (3.22%), Staphylococcus haemolyticus (3.08%), and Staphylococcus aureus (2.94%), accounting for 69.43% of the total pathogenic bacteria. Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Klebsiella pneumoniae subspecies, and Acinetobacter baumannii were the main pathogenic bacteria isolated from respiratory tract specimens; Enterococcus faecium was the main pathogenic bacterium isolated from bile, ascites, and drainage fluid specimens; Escherichia coli, Staphylococcus epidermidis, and Klebsiella pneumoniae subspecies were the main pathogenic bacteria isolated from blood specimens. Drug sensitivity data showed that Enterobacterales bacteria had a relatively high resistance rate to cephalosporins and fluoroquinolones and a resistance rate of < 10% to amikacin among aminoglycosides, with no strains resistant to tigecycline; compared with Escherichia coli, Klebsiella pneumoniae subspecies had a higher resistance rate to meropenem (14.71% vs 5.66%) and imipenem (11.35% vs 6.29%); non-fermentative bacteria had a relatively high resistance rate to carbapenems, with a resistance rate of < 10% to tigecycline and colistin. Among Gram-positive cocci, Enterococcus faecium had a resistance rate of 6.17% to vancomycin and 2.44% to quinupristin/dalfopristin, with no strains resistant to tigecycline and linezolid; Staphylococcus epidermidis had a resistance rate of > 50% to macrolides, fluoroquinolones, sulfonamides, and lincomycin, and a small part of these strains were resistant to linezolid and quinupristin/dalfopristin (< 3%), with no Staphylococcus epidermidis strains resistant to tigecycline and vancomycin. A total of 287 drug-resistant strains were monitored, accounting for 13%, among which there were 128 carbapenem-resistant Acinetobacter baumannii strains, 88 carbapenem-resistant Pseudomonas aeruginosa strains, 26 carbapenem-resistant Klebsiella pneumoniae subspecies strains, 11 carbapenem-resistant Escherichia coli strains, 23 methicillin-resistant Staphylococcus aureus strains, and 11 vancomycin-resistant Enterococcus strains. The carbapenem-resistant Klebsiella pneumoniae subspecies strains mainly produced serine carbapenemase, and the carbapenem-resistant Escherichia coli strains mainly produced metal β-lactamase. Conclusion Gram-negative bacteria are the main pathogenic bacteria for infection after liver transplantation, and there are differences in the distribution of pathogenic bacteria between different types of specimens. The resistance rate of some strains tend to increase, and therefore, it is necessary to strengthen the management of nosocomial infection and antibiotics.
- Liver Transplantation,
- Bacterial Infections,
- Drug Resistance, Bacterial

FullText(HTML)

References(21)

References

[1]	ZHAO Y, ZHAO LJ. Research advances in the risk factors for infection after liver transplantation[J]. J Clin Hepatol, 2021, 37(8): 1957-1962. DOI: 10.3969/j.issn.1001-5256.2021.08.046. 赵云, 赵礼金. 肝移植术后感染相关危险因素的研究进展[J]. 临床肝胆病杂志, 2021, 37(8): 1957-1962. DOI: 10.3969/j.issn.1001-5256.2021.08.046.
[2]	WANG XC, GE J, CHEN YW, et al. Research progress in detection of pathogen infection after organ transplantation[J]. Ogran Transplant, 2018, 9(6): 474-477. DOI: 10.3969/j.issn.1674-7445.2018.06.015. 王啸晨, 葛军, 陈雅文, 等. 器官移植术后病原体感染检测研究进展[J]. 器官移植, 2018, 9(6): 474-477. DOI: 10.3969/j.issn.1674-7445.2018.06.015.
[3]	KIM SI. Bacterial infection after liver transplantation[J]. World J Gastroenterol, 2014, 20(20): 6211-6220. DOI: 10.3748/wjg.v20.i20.6211.
[4]	LEE JS, LEE SH, KIM KS, et al. Bacterial infection monitoring in the early period after liver transplantation[J]. Ann Surg Treat Res, 2018, 94(3): 154-158. DOI: 10.4174/astr.2018.94.3.154.
[5]	KAWECKI D, PACHOLCZYK M, LAGIEWSKA B, et al. Bacterial and fungal infections in the early post- transplantation period after liver transplantation: etiologic agents and their susceptibility[J]. Transplant Proc, 2014, 46(8): 2777-2781. DOI: 10.1016/j.transproceed.2014.08.031.
[6]	DORSCHNER P, MCELROY LM, ISON MG. Nosocomial infections within the first month of solid organ transplantation[J]. Transpl Infect Dis, 2014, 16(2): 171-187. DOI: 10.1111/tid.12203.
[7]	SHANG H, WANG YS, SHEN ZY. National Clinical Laboratory Operating Procedures (4th Edition)[M]. Beijing: People's Health Publishing House, 2015: 580-831. 尚红, 王毓三, 申子瑜. 全国临床检验操作规程(第四版)[M]. 北京: 人民卫生出版社, 2015: 580-831.
[8]	Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 29th. CLSI M100[S]. USA: Clinical and Laboratory Standards Institute, 2019.
[9]	Society of Clinical Microbiology and Infection of China International Exchange and Promotion Association for Medical and Healthcare, Clinical Microbiology Group of the Laboratory Medicine Society of the Chinese Medical Association, Clinical Microbiology Group of the Microbiology and Immunology Society of the Chinese Medical Association. Expert consensus on polymyxins, tigecycline and ceftazidime/avibactam susceptibility testing[J]. Chin J Lab Med, 2020, 43(10): 964-972. DOI: 10.3760/cma.j.cn114452-20200719-00619. 中国医疗保健国际交流促进会临床微生物与感染分会, 中华医学会检验医学分会临床微生物学组, 中华医学会微生物学与免疫学分会临床微生物学组. 多黏菌素类与替加环素及头孢他啶/阿维巴坦药敏方法和报告专家共识[J]. 中华检验医学杂志, 2020, 43(10): 964-972. DOI: 10.3760/cma.j.cn114452-20200719-00619.
[10]	Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 32nd. CLSI M100[S]. USA: Clinical and Laboratory Standards Institute, 2022.
[11]	XING F, YANG CS, JIN Y, et al. Distribution and drug resistance of microbial pathogens in 120 patients with infectious diseases in a hospital[J]. Clin J Med Offic, 2021, 49(9): 1023-1025. DOI: 10.16680/j.1671-3826.2021.09.21. 邢飞, 杨春生, 金跃, 等. 某院120例感染性患者微生物病原菌分布及耐药性分析[J]. 临床军医杂志, 2021, 49(9): 1023-1025. DOI: 10.16680/j.1671-3826.2021.09.21.
[12]	CHENG YJ. Analysis of distribution and drug resistance of 145 pathogenic bacteria causing postoperative infections in liver transplantation patients[J]. Chin J Health Lab Technol, 2018, 28(4): 470-472. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWJZ201804027.htm 程燕洁. 145例肝移植患者术后医院感染病原菌的分布及耐药性分析[J]. 中国卫生检验杂志, 2018, 28(4): 470-472. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWJZ201804027.htm
[13]	WU JD, MU XX, HAN GY, et al. Analysis on distribution and drug resistance of 1380 strains of pathogens infected after liver transplantation from 2012 to 2015[J]. Drugs & Clinic, 2015, 30(12): 1546-1549. DOI: 10.7501/j.issn.1674-5515.2015.12.027. 吴金道, 母小新, 韩国勇, 等. 2012—2015年1380株肝移植术后感染病原菌的分布及耐药性分析[J]. 现代药物与临床, 2015, 30(12): 1546-1549. DOI: 10.7501/j.issn.1674-5515.2015.12.027.
[14]	JIANG AD, YANG JY, XU T. Analysis on distribution and drug resistance of pathogens infected in adult deceased donor liver transplant recipients[J]. J Chin Antibiotics, 2020, 45(9): 924-928. DOI: 10.3969/j.issn.1001-8689.2020.09.014. 蒋艾豆, 杨家印, 徐珽. 成人尸体肝移植受者感染病原菌分布及耐药性分析[J]. 中国抗生素杂志, 2020, 45(9): 924-928. DOI: 10.3969/j.issn.1001-8689.2020.09.014.
[15]	YAO S, YAGI S, UOZUMI R, et al. A high portal venous pressure gradient increases gut-related bacteremia and consequent early mortality after living donor liver transplantation[J]. Transplantation, 2018, 102(4): 623-631. DOI: 10.1097/TP.0000000000002047.
[16]	ANESI JA, BLUMBERG EA, ABBO LM. Perioperative antibiotic prophylaxis to prevent surgical site infections in solid organ transplantation[J]. Transplantation, 2018, 102(1): 21-34. DOI: 10.1097/TP.0000000000001848.
[17]	Chinese Society of Organ Transplantation, Chinese Medical Association. Technical specifications for the diagnosis and treatment of drug resistant bacteria infection after organ transplantation (2019 edition)[J]. Ogran Transplant, 2019, 10(4): 352-358. DOI: 10.3969/j.issn.1674-7445.2019.04.002. 中华医学会器官移植学分会. 器官移植术后耐药菌感染诊疗技术规范(2019版)[J]. 器官移植, 2019, 10(4): 352-358. DOI: 10.3969/j.issn.1674-7445.2019.04.002.
[18]	HU FP, GUO Y, ZHU DM, et al. CHINET surveillance of bacterial resistance: results of 2020[J]. Chin J Infect Chemother, 2021, 21(4): 377-387. DOI: 10.16718/j.1009-7708.2021.04.001. 胡付品, 郭燕, 朱德妹, 等. 2020年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志, 2021, 21(4): 377-387. DOI: 10.16718/j.1009-7708.2021.04.001.
[19]	KIM YJ, YOON JH, KIM SI, et al. High mortality associated with Acinetobacter species infection in liver transplant patients[J]. Transplant Proc, 2011, 43(6): 2397-2399. DOI: 10.1016/j.transproceed.2011.06.011.
[20]	SHEN CY, WANG J, LIN T, et al. Distribution and risk factors of multi-drug resistant bacteria infection after liver transplantation[J]. J Hepatopancreatobiliary Surg, 2020, 32(6): 355-360. DOI: 10.11952/j.issn.1007-1954.2020.06.008. 申存毅, 王婧, 林婷, 等. 肝移植术后多重耐药菌感染分布特征及危险因素[J]. 肝胆胰外科杂志, 2020, 32(6): 355-360. DOI: 10.11952/j.issn.1007-1954.2020.06.008.
[21]	YU H, XU XS, LI M, et al. Consensus statement on laboratory detection and clinical report of carbapenemases among Enterobacterales[J]. Chin J Infect Chemother, 2020, 20(6): 671-680. DOI: 10.16718/j.1009-7708.2020.06.015. 喻华, 徐雪松, 李敏, 等. 肠杆菌目细菌碳青霉烯酶的实验室检测和临床报告规范专家共识[J]. 中国感染与化疗杂志, 2020, 20(6): 671-680. DOI: 10.16718/j.1009-7708.2020.06.015.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(12) / Tables(1)

Get Citation

PDF

XML

Article Metrics

Article views (416) PDF downloads(54)

Distribution and drug resistance of pathogenic bacteria for infection after liver transplantation

DOI: 10.3969/j.issn.1001-5256.2023.06.017

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Distribution and drug resistance of pathogenic bacteria for infection after liver transplantation

DOI: 10.3969/j.issn.1001-5256.2023.06.017

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content